The U.S. Food and Drug Administration on Monday approved a new indication for Filspari (sparsentan) tablets for reducing proteinuria (abnormal levels of protein in the urine) in […]

Image By: JaCinta S. Batson, M.S., M.B.A., Director, Satellite Laboratory Branch, National Forensic Chemistry Center, Office of the Chief Scientist  Satellite laboratories stationed inside high-volume international […]

On This Page Date: June 23, 2026 Time: 1:00 p.m. – 2:30 p.m. ET Location: Event Location Attend In Person or OnlineVirtual: via webcastIn Person: FDA […]

Date: April 29, 2026 Time: 12:00 p.m. – 1:00 p.m. ET Register to Attend On Wednesday, April 29, 2026, FDA is hosting a free public webinar […]

Delivery Method: VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States […]

Delivery Method: Via Electronic Mail – Delivery and Read Receipt Requested Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing […]

Delivery Method: VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED Product: Drugs Recipient: Tuyo Health, Inc. dba Tuyo Health 382 NE 191st ST PMB 353681Miami, FL 33179United States […]

Delivery Method: Via Electronic Mail – Delivery and Read Receipt Requested Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER […]

Delivery Method: VIA ELECTRONIC MAIL READ/DELIVERY RECEIPT REQUESTED Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States […]